Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEFLUNOMIDE vs LENACAPAVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEFLUNOMIDE vs LENACAPAVIR: Safety Overview

Metric LEFLUNOMIDE LENACAPAVIR
Total FAERS Reports 56,539 502
Deaths Reported 5,283 32
Death Rate 9.3% 6.4%
Hospitalizations 13,923 42
Average Patient Age 51.3 yrs 50.0 yrs
% Female Patients 87.3% 24.7%
FDA Approval Date Apr 24, 2019 Dec 22, 2022
Manufacturer Alembic Pharmaceuticals Inc. Gilead Sciences, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription